Industry: Chemical & Material
Published Date: 2025-07-31
Pages: 182 Pages
Report ld: 4812349
Request Sample
Customized Report
Pharma Grade Rigid Plastic Film Market Size(US$)

CAGR 2025-2031
5.2%
Market Size,2031
USD 2,617
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Pharma Grade Rigid Plastic Film market is projected to grow from US$ 1844 million in 2024 to US$ 2617 million by 2031, at a CAGR of 5.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Pharma Grade Rigid Plastic Film is a specialized hard plastic material meticulously designed for pharmaceutical packaging applications. Characterized by its notable strength and rigidity, it serves as a robust physical barrier, safeguarding medications from potential damage caused by external forces like compression, impact, or vibration during transportation, storage, and distribution. Manufactured from plastic resins that meet stringent pharmaceutical standards, such as polyvinyl chloride (PVC), polyethylene terephthalate (PET), and others, its production adheres to the most exacting quality and safety regulations in the pharmaceutical packaging industry.
From a downstream perspective, Tablet Packaging accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Pharma Grade Rigid Plastic Film leading manufacturers including Klöckner Pentaplast, Perlen Packaging, Liveo Research, TekniPlex, Sumitomo Bakelite, Mitsubishi Chemical, ETIMEX Primary Packaging, Taisei Kako, Neelam Global, Pharma Peak, etc., dominate supply; the top five capture approximately % of global revenue, with Klöckner Pentaplast leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Pharma Grade Rigid Plastic Film market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the Pharma Grade Rigid Plastic Film study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.
Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.
Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Pharma Grade Rigid Plastic Film: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Pharma Grade Rigid Plastic Film Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 PVC Rigid Sheet
1.2.3 PVC/PE Rigid Sheet
1.2.4 PVC/PVDC Rigid Sheet
1.2.5 PVC/PCTFE Rigid Sheet
1.2.6 PP Rigid Sheet
1.2.7 Others
1.3 Market Segmentation by Application
1.3.1 Global Pharma Grade Rigid Plastic Film Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Tablet Packaging
1.3.3 Capsule Packing
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Pharma Grade Rigid Plastic Film Revenue Estimates and Forecasts 2020-2031
2.2 Global Pharma Grade Rigid Plastic Film Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Pharma Grade Rigid Plastic Film Sales Estimates and Forecasts 2020-2031
2.4 Global Pharma Grade Rigid Plastic Film Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Global Production Analysis
3.1 Global Pharma Grade Rigid Plastic Film Production Capacity and Utilization Rates (2020–2031)
3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)
3.3 Regional Production Dynamics
3.3.1 Historic Production by Region (2020-2025)
3.3.2 Forecasted Production by Region (2026-2031)
3.3.3 Production Market Share by Region (2020-2031)
3.3.4 Regulatory and Trade Policy Impact on Production
3.3.5 Production Capacity Enablers and Constraints
3.4 Key Regional Production Hubs
3.4.1 North America
3.4.2 Europe
3.4.3 China
3.4.4 Japan
4 Competition by Manufacturers
4.1 Global Pharma Grade Rigid Plastic Film Sales by Manufacturers
4.1.1 Global Sales Volume by Manufacturers (2020-2025)
4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
4.2 Global Pharma Grade Rigid Plastic Film Manufacturer Revenue Rankings and Tiers
4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
4.3 Manufacturer Profitability Profiles and Pricing Strategies
4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
4.3.2 Manufacturer-Level Price Trends (2020-2025)
4.4 Key Manufacturers Manufacturing Base and Headquarters
4.5 Main Product Type Market Size by Manufacturers
4.5.1 PVC Rigid Sheet Market Size by Manufacturers
4.5.2 PVC/PE Rigid Sheet Market Size by Manufacturers
4.5.3 PVC/PVDC Rigid Sheet Market Size by Manufacturers
4.5.4 PVC/PCTFE Rigid Sheet Market Size by Manufacturers
4.5.5 PP Rigid Sheet Market Size by Manufacturers
4.5.6 Others Market Size by Manufacturers
4.6 Global Pharma Grade Rigid Plastic Film Market Concentration and Dynamics
4.6.1 Global Market Concentration (CR5 and HHI)
4.6.2 Entrant/Exit Impact Analysis
4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
5 Global Product Segmentation Analysis
5.1 Global Pharma Grade Rigid Plastic Film Sales Performance by Type
5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
5.1.2 Global Sales Market Share by Type (2020-2031)
5.2 Global Pharma Grade Rigid Plastic Film Revenue Trends by Type
5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
5.2.2 Global Revenue Market Share by Type (2020-2031)
5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
5.4 Product Technology Differentiation
5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
5.5.1 High-Growth Niches and Adoption Drivers
5.5.2 Profitability Hotspots and Cost Drivers
5.5.3 Substitution Threats
6 Global Downstream Application Analysis
6.1 Global Pharma Grade Rigid Plastic Film Sales by Application
6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
6.1.2 Global Sales Market Share by Application (2020-2031)
6.1.3 High-Growth Application Identification
6.1.4 Emerging Application Case Studies
6.2 Global Pharma Grade Rigid Plastic Film Revenue by Application
6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
6.2.2 Revenue Market Share by Application (2020-2031)
6.3 Global Pricing Dynamics by Application (2020-2031)
6.4 Downstream Customer Analysis
6.4.1 Top Customers by Region
6.4.2 Top Customers by Application
7 North America
7.1 North America Sales Volume and Revenue (2020-2031)
7.2 North America Key Manufacturers Sales Revenue in 2024
7.3 North America Pharma Grade Rigid Plastic Film Sales and Revenue by Type (2020-2031)
7.4 North America Pharma Grade Rigid Plastic Film Sales and Revenue by Application (2020-2031)
7.5 North America Growth Accelerators and Market Barriers
7.6 North America Pharma Grade Rigid Plastic Film Market Size by Country
7.6.1 North America Revenue by Country
7.6.2 North America Sales Trends by Country
7.6.3 US
7.6.4 Canada
7.6.5 Mexico
8 Europe
8.1 Europe Sales Volume and Revenue (2020-2031)
8.2 Europe Key Manufacturers Sales Revenue in 2024
8.3 Europe Pharma Grade Rigid Plastic Film Sales and Revenue by Type (2020-2031)
8.4 Europe Pharma Grade Rigid Plastic Film Sales and Revenue by Application (2020-2031)
8.5 Europe Growth Accelerators and Market Barriers
8.6 Europe Pharma Grade Rigid Plastic Film Market Size by Country
8.6.1 Europe Revenue by Country
8.6.2 Europe Sales Trends by Country
8.6.3 Germany
8.6.4 France
8.6.5 U.K.
8.6.6 Italy
8.6.7 Russia
9 Asia-Pacific
9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
9.3 Asia-Pacific Pharma Grade Rigid Plastic Film Sales and Revenue by Type (2020-2031)
9.4 Asia-Pacific Pharma Grade Rigid Plastic Film Sales and Revenue by Application (2020-2031)
9.5 Asia-Pacific Pharma Grade Rigid Plastic Film Market Size by Region
9.5.1 Asia-Pacific Revenue by Region
9.5.2 Asia-Pacific Sales Trends by Region
9.6 Asia-Pacific Growth Accelerators and Market Barriers
9.7 Southeast Asia
9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand
9.8 China
9.9 Japan
9.10 South Korea
9.11 China Taiwan
9.12 India
10 Central and South America
10.1 Central and South America Sales Volume and Revenue (2020-2031)
10.2 Central and South America Key Manufacturers Sales Revenue in 2024
10.3 Central and South America Pharma Grade Rigid Plastic Film Sales and Revenue by Type (2020-2031)
10.4 Central and South America Pharma Grade Rigid Plastic Film Sales and Revenue by Application (2020-2031)
10.5 Central and South America Investment Opportunities and Key Challenges
10.6 Central and South America Pharma Grade Rigid Plastic Film Market Size by Country
10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 Brazil
10.6.3 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
11.3 Middle East and Africa Pharma Grade Rigid Plastic Film Sales and Revenue by Type (2020-2031)
11.4 Middle East and Africa Pharma Grade Rigid Plastic Film Sales and Revenue by Application (2020-2031)
11.5 Middle East and Africa Investment Opportunities and Key Challenges
11.6 Middle East and Africa Pharma Grade Rigid Plastic Film Market Size by Country
11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
11.6.2 GCC Countries
11.6.3 Turkey
11.6.4 Egypt
11.6.5 South Africa
12 Corporate Profile
12.1 Klöckner Pentaplast
12.1.1 Klöckner Pentaplast Corporation Information
12.1.2 Klöckner Pentaplast Business Overview
12.1.3 Klöckner Pentaplast Pharma Grade Rigid Plastic Film Product Models, Descriptions and Specifications
12.1.4 Klöckner Pentaplast Pharma Grade Rigid Plastic Film Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.1.5 Klöckner Pentaplast Pharma Grade Rigid Plastic Film Sales by Product in 2024
12.1.6 Klöckner Pentaplast Pharma Grade Rigid Plastic Film Sales by Application in 2024
12.1.7 Klöckner Pentaplast Pharma Grade Rigid Plastic Film Sales by Geographic Area in 2024
12.1.8 Klöckner Pentaplast Pharma Grade Rigid Plastic Film SWOT Analysis
12.1.9 Klöckner Pentaplast Recent Developments
12.2 Perlen Packaging
12.2.1 Perlen Packaging Corporation Information
12.2.2 Perlen Packaging Business Overview
12.2.3 Perlen Packaging Pharma Grade Rigid Plastic Film Product Models, Descriptions and Specifications
12.2.4 Perlen Packaging Pharma Grade Rigid Plastic Film Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.2.5 Perlen Packaging Pharma Grade Rigid Plastic Film Sales by Product in 2024
12.2.6 Perlen Packaging Pharma Grade Rigid Plastic Film Sales by Application in 2024
12.2.7 Perlen Packaging Pharma Grade Rigid Plastic Film Sales by Geographic Area in 2024
12.2.8 Perlen Packaging Pharma Grade Rigid Plastic Film SWOT Analysis
12.2.9 Perlen Packaging Recent Developments
12.3 Liveo Research
12.3.1 Liveo Research Corporation Information
12.3.2 Liveo Research Business Overview
12.3.3 Liveo Research Pharma Grade Rigid Plastic Film Product Models, Descriptions and Specifications
12.3.4 Liveo Research Pharma Grade Rigid Plastic Film Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.3.5 Liveo Research Pharma Grade Rigid Plastic Film Sales by Product in 2024
12.3.6 Liveo Research Pharma Grade Rigid Plastic Film Sales by Application in 2024
12.3.7 Liveo Research Pharma Grade Rigid Plastic Film Sales by Geographic Area in 2024
12.3.8 Liveo Research Pharma Grade Rigid Plastic Film SWOT Analysis
12.3.9 Liveo Research Recent Developments
12.4 TekniPlex
12.4.1 TekniPlex Corporation Information
12.4.2 TekniPlex Business Overview
12.4.3 TekniPlex Pharma Grade Rigid Plastic Film Product Models, Descriptions and Specifications
12.4.4 TekniPlex Pharma Grade Rigid Plastic Film Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.4.5 TekniPlex Pharma Grade Rigid Plastic Film Sales by Product in 2024
12.4.6 TekniPlex Pharma Grade Rigid Plastic Film Sales by Application in 2024
12.4.7 TekniPlex Pharma Grade Rigid Plastic Film Sales by Geographic Area in 2024
12.4.8 TekniPlex Pharma Grade Rigid Plastic Film SWOT Analysis
12.4.9 TekniPlex Recent Developments
12.5 Sumitomo Bakelite
12.5.1 Sumitomo Bakelite Corporation Information
12.5.2 Sumitomo Bakelite Business Overview
12.5.3 Sumitomo Bakelite Pharma Grade Rigid Plastic Film Product Models, Descriptions and Specifications
12.5.4 Sumitomo Bakelite Pharma Grade Rigid Plastic Film Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.5.5 Sumitomo Bakelite Pharma Grade Rigid Plastic Film Sales by Product in 2024
12.5.6 Sumitomo Bakelite Pharma Grade Rigid Plastic Film Sales by Application in 2024
12.5.7 Sumitomo Bakelite Pharma Grade Rigid Plastic Film Sales by Geographic Area in 2024
12.5.8 Sumitomo Bakelite Pharma Grade Rigid Plastic Film SWOT Analysis
12.5.9 Sumitomo Bakelite Recent Developments
12.6 Mitsubishi Chemical
12.6.1 Mitsubishi Chemical Corporation Information
12.6.2 Mitsubishi Chemical Business Overview
12.6.3 Mitsubishi Chemical Pharma Grade Rigid Plastic Film Product Models, Descriptions and Specifications
12.6.4 Mitsubishi Chemical Pharma Grade Rigid Plastic Film Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.6.5 Mitsubishi Chemical Recent Developments
12.7 ETIMEX Primary Packaging
12.7.1 ETIMEX Primary Packaging Corporation Information
12.7.2 ETIMEX Primary Packaging Business Overview
12.7.3 ETIMEX Primary Packaging Pharma Grade Rigid Plastic Film Product Models, Descriptions and Specifications
12.7.4 ETIMEX Primary Packaging Pharma Grade Rigid Plastic Film Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.7.5 ETIMEX Primary Packaging Recent Developments
12.8 Taisei Kako
12.8.1 Taisei Kako Corporation Information
12.8.2 Taisei Kako Business Overview
12.8.3 Taisei Kako Pharma Grade Rigid Plastic Film Product Models, Descriptions and Specifications
12.8.4 Taisei Kako Pharma Grade Rigid Plastic Film Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.8.5 Taisei Kako Recent Developments
12.9 Neelam Global
12.9.1 Neelam Global Corporation Information
12.9.2 Neelam Global Business Overview
12.9.3 Neelam Global Pharma Grade Rigid Plastic Film Product Models, Descriptions and Specifications
12.9.4 Neelam Global Pharma Grade Rigid Plastic Film Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.9.5 Neelam Global Recent Developments
12.10 Pharma Peak
12.10.1 Pharma Peak Corporation Information
12.10.2 Pharma Peak Business Overview
12.10.3 Pharma Peak Pharma Grade Rigid Plastic Film Product Models, Descriptions and Specifications
12.10.4 Pharma Peak Pharma Grade Rigid Plastic Film Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.10.5 Pharma Peak Recent Developments
12.11 Zibo Zhongnan Pharmaceutical Packaging
12.11.1 Zibo Zhongnan Pharmaceutical Packaging Corporation Information
12.11.2 Zibo Zhongnan Pharmaceutical Packaging Business Overview
12.11.3 Zibo Zhongnan Pharmaceutical Packaging Pharma Grade Rigid Plastic Film Product Models, Descriptions and Specifications
12.11.4 Zibo Zhongnan Pharmaceutical Packaging Pharma Grade Rigid Plastic Film Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.11.5 Zibo Zhongnan Pharmaceutical Packaging Recent Developments
12.12 Zhejiang Tiancheng Medical Packing
12.12.1 Zhejiang Tiancheng Medical Packing Corporation Information
12.12.2 Zhejiang Tiancheng Medical Packing Business Overview
12.12.3 Zhejiang Tiancheng Medical Packing Pharma Grade Rigid Plastic Film Product Models, Descriptions and Specifications
12.12.4 Zhejiang Tiancheng Medical Packing Pharma Grade Rigid Plastic Film Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.12.5 Zhejiang Tiancheng Medical Packing Recent Developments
12.13 Jiangsu Kaiwei Pharmaceutical Packaging
12.13.1 Jiangsu Kaiwei Pharmaceutical Packaging Corporation Information
12.13.2 Jiangsu Kaiwei Pharmaceutical Packaging Business Overview
12.13.3 Jiangsu Kaiwei Pharmaceutical Packaging Pharma Grade Rigid Plastic Film Product Models, Descriptions and Specifications
12.13.4 Jiangsu Kaiwei Pharmaceutical Packaging Pharma Grade Rigid Plastic Film Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.13.5 Jiangsu Kaiwei Pharmaceutical Packaging Recent Developments
12.14 HySum
12.14.1 HySum Corporation Information
12.14.2 HySum Business Overview
12.14.3 HySum Pharma Grade Rigid Plastic Film Product Models, Descriptions and Specifications
12.14.4 HySum Pharma Grade Rigid Plastic Film Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.14.5 HySum Recent Developments
12.15 Hangzhou Plastics Industry
12.15.1 Hangzhou Plastics Industry Corporation Information
12.15.2 Hangzhou Plastics Industry Business Overview
12.15.3 Hangzhou Plastics Industry Pharma Grade Rigid Plastic Film Product Models, Descriptions and Specifications
12.15.4 Hangzhou Plastics Industry Pharma Grade Rigid Plastic Film Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.15.5 Hangzhou Plastics Industry Recent Developments
12.16 Jiangxi Chunguang New Material Technology
12.16.1 Jiangxi Chunguang New Material Technology Corporation Information
12.16.2 Jiangxi Chunguang New Material Technology Business Overview
12.16.3 Jiangxi Chunguang New Material Technology Pharma Grade Rigid Plastic Film Product Models, Descriptions and Specifications
12.16.4 Jiangxi Chunguang New Material Technology Pharma Grade Rigid Plastic Film Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.16.5 Jiangxi Chunguang New Material Technology Recent Developments
12.17 Jiangsu Jincai Technology
12.17.1 Jiangsu Jincai Technology Corporation Information
12.17.2 Jiangsu Jincai Technology Business Overview
12.17.3 Jiangsu Jincai Technology Pharma Grade Rigid Plastic Film Product Models, Descriptions and Specifications
12.17.4 Jiangsu Jincai Technology Pharma Grade Rigid Plastic Film Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.17.5 Jiangsu Jincai Technology Recent Developments
12.18 Shenzhen TLX Science and Technology
12.18.1 Shenzhen TLX Science and Technology Corporation Information
12.18.2 Shenzhen TLX Science and Technology Business Overview
12.18.3 Shenzhen TLX Science and Technology Pharma Grade Rigid Plastic Film Product Models, Descriptions and Specifications
12.18.4 Shenzhen TLX Science and Technology Pharma Grade Rigid Plastic Film Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.18.5 Shenzhen TLX Science and Technology Recent Developments
12.19 Sichuan Huili Industry
12.19.1 Sichuan Huili Industry Corporation Information
12.19.2 Sichuan Huili Industry Business Overview
12.19.3 Sichuan Huili Industry Pharma Grade Rigid Plastic Film Product Models, Descriptions and Specifications
12.19.4 Sichuan Huili Industry Pharma Grade Rigid Plastic Film Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.19.5 Sichuan Huili Industry Recent Developments
12.20 Henan Wanshun Technology
12.20.1 Henan Wanshun Technology Corporation Information
12.20.2 Henan Wanshun Technology Business Overview
12.20.3 Henan Wanshun Technology Pharma Grade Rigid Plastic Film Product Models, Descriptions and Specifications
12.20.4 Henan Wanshun Technology Pharma Grade Rigid Plastic Film Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.20.5 Henan Wanshun Technology Recent Developments
12.21 Jiangsu Fuxin Huakang Packaging Material
12.21.1 Jiangsu Fuxin Huakang Packaging Material Corporation Information
12.21.2 Jiangsu Fuxin Huakang Packaging Material Business Overview
12.21.3 Jiangsu Fuxin Huakang Packaging Material Pharma Grade Rigid Plastic Film Product Models, Descriptions and Specifications
12.21.4 Jiangsu Fuxin Huakang Packaging Material Pharma Grade Rigid Plastic Film Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.21.5 Jiangsu Fuxin Huakang Packaging Material Recent Developments
13 Value Chain and Supply-Chain Analysis
13.1 Pharma Grade Rigid Plastic Film Industry Chain
13.2 Pharma Grade Rigid Plastic Film Upstream Materials Analysis
13.2.1 Raw Materials
13.2.2 Key Suppliers Market Share & Risk Assessment
13.3 Pharma Grade Rigid Plastic Film Integrated Production Analysis
13.3.1 Manufacturing Footprint Analysis
13.3.2 Production Technology Overview
13.3.3 Regional Cost Drivers
13.4 Pharma Grade Rigid Plastic Film Sales Channels and Distribution Networks
13.4.1 Sales Channels
13.4.2 Distributors
14 Pharma Grade Rigid Plastic Film Market Dynamics
14.1 Industry Trends and Evolution
14.2 Market Growth Drivers and Emerging Opportunities
14.3 Market Challenges, Risks, and Restraints
15 Key Findings in the Global Pharma Grade Rigid Plastic Film Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Pharma Grade Rigid Plastic Film market is projected to grow from US$ 1931 million in 2025 to US$ 2740 million by 2032, at a CAGR of 5.2% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-24
Pages: 191
USD 4900.00
(Single User License)
The global Pharma Grade Rigid Plastic Film market size was US$ 1931 million in 2025 and is forecast to reach a readjusted size of US$ 2740 million by 2032 with a CAGR of 5.2% during the forecast period 2026-2032.
Published Date: 2026-03-24
Pages: 115
USD 4250.00
(Single User License)
The global market for Pharma Grade Rigid Plastic Film was estimated to be worth US$ 1931 million in 2025 and is projected to reach US$ 2740 million, growing at a CAGR of 5.2% from 2026 to 2032.
Published Date: 2026-01-19
Pages: 151
USD 3950.00
(Single User License)
The global Pharma Grade Rigid Plastic Film market was valued at US$ 1931 million in 2025 and is anticipated to reach US$ 2740 million by 2032, at a CAGR of 5.2% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 156
USD 2900.00
(Single User License)
The global Pharma Grade Rigid Plastic Film market size was US$ 1844 million in 2024 and is forecast to a readjusted size of US$ 2617 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 115
USD 4250.00
(Single User License)
The global market for Pharma Grade Rigid Plastic Film was estimated to be worth US$ 1844 million in 2024 and is forecast to a readjusted size of US$ 2617 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 152
USD 3950.00
(Single User License)
The global market for Pharma Grade Rigid Plastic Film was valued at US$ 1844 million in the year 2024 and is projected to reach a revised size of US$ 2617 million by 2031, growing at a CAGR of 5.2% during the forecast period.
Published Date: 2025-03-10
Pages: 122
USD 2900.00
(Single User License)
The global Pharma Grade Rigid Plastic Film revenue was US$ 1793 million in 2023 and is forecast to a readjusted size of US$ 2500 million by 2030 with a CAGR of 5.2% during the review period (2024-2030).
Published Date: 2024-12-11
Pages: 163
USD 4350.00
(Single User License)
Valued at US$ 1844 million in 2024, the global Pharma Grade Rigid Plastic Film market is forecast to reach US$ 2500 million by 2030, at a CAGR of 5.2% during the forecast period.
Published Date: 2024-12-11
Pages: 182
USD 4900.00
(Single User License)
The global market for Pharma Grade Rigid Plastic Film was estimated to be worth US$ 1793 million in 2023 and is forecast to a readjusted size of US$ 2500 million by 2030 with a CAGR of 5.2% during the forecast period 2024-2030.
Published Date: 2024-12-11
Pages: 152
USD 3950.00
(Single User License)
The global Pharma Grade Rigid Plastic Film market is projected to grow from US$ 1931 million in 2025 to US$ 2740 million by 2032, at a CAGR of 5.2% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-24
Pages: 191
The global Pharma Grade Rigid Plastic Film market size was US$ 1931 million in 2025 and is forecast to reach a readjusted size of US$ 2740 million by 2032 with a CAGR of 5.2% during the forecast period 2026-2032.
Published: 2026-03-24
Pages: 115
The global market for Pharma Grade Rigid Plastic Film was estimated to be worth US$ 1931 million in 2025 and is projected to reach US$ 2740 million, growing at a CAGR of 5.2% from 2026 to 2032.
Published: 2026-01-19
Pages: 151
The global Pharma Grade Rigid Plastic Film market was valued at US$ 1931 million in 2025 and is anticipated to reach US$ 2740 million by 2032, at a CAGR of 5.2% from 2026 to 2032.
Published: 2026-01-08
Pages: 156
The global Pharma Grade Rigid Plastic Film market size was US$ 1844 million in 2024 and is forecast to a readjusted size of US$ 2617 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 115
The global market for Pharma Grade Rigid Plastic Film was estimated to be worth US$ 1844 million in 2024 and is forecast to a readjusted size of US$ 2617 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 152
The global market for Pharma Grade Rigid Plastic Film was valued at US$ 1844 million in the year 2024 and is projected to reach a revised size of US$ 2617 million by 2031, growing at a CAGR of 5.2% during the forecast period.
Published: 2025-03-10
Pages: 122
The global Pharma Grade Rigid Plastic Film revenue was US$ 1793 million in 2023 and is forecast to a readjusted size of US$ 2500 million by 2030 with a CAGR of 5.2% during the review period (2024-2030).
Published: 2024-12-11
Pages: 163
Valued at US$ 1844 million in 2024, the global Pharma Grade Rigid Plastic Film market is forecast to reach US$ 2500 million by 2030, at a CAGR of 5.2% during the forecast period.
Published: 2024-12-11
Pages: 182
The global market for Pharma Grade Rigid Plastic Film was estimated to be worth US$ 1793 million in 2023 and is forecast to a readjusted size of US$ 2500 million by 2030 with a CAGR of 5.2% during the forecast period 2024-2030.
Published: 2024-12-11
Pages: 152
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now